Related by context. All words. (Click for frequent words.) 68 allogenic 67 autologous 67 allogeneic stem cell 66 hematopoietic stem cell 65 autologous bone marrow 65 HLA matched 63 transplantation HCT 63 rFVIIa 62 leukapheresis 62 mononuclear cells 62 allogeneic bone marrow 61 Allogeneic 61 autologous transplant 61 donor pancreases 61 cryopreserved 61 adult mesenchymal stem 61 transplantation HSCT 61 CMV seropositive 60 CD# + [001] 60 adipose tissue derived 60 von Willebrand factor 60 stem cell transplantation 60 coagulation factors 60 allogeneic transplants 60 factor G CSF 60 MYLOTARG 60 vWF 60 placental stem cells 59 hA# 59 Autologous 59 Privigen 59 FVIII 59 hematopoietic 59 azacytidine 59 CsA 59 hematopoietic cell 59 hematopoietic cells 59 allogeneic SCT 59 immunologically matched 59 autologous SCT 59 autologous transplants 59 granulocyte colony stimulating 59 bypass grafting 59 MGd 59 autografts 59 calcineurin inhibitor 59 cells hESCs 59 allogeneic hematopoietic stem cell 59 bone marrow derived 59 hematopoietic reconstitution 59 granulocyte 58 mesenchymal stem cell 58 CMV disease 58 Islet transplantation 58 RBC transfusions 58 autologous cells 58 adipose stem cells 58 Umbilical cord stem cells 58 MyVax ® 58 autologous transplantation 58 interleukin IL -# 58 HSPCs 58 bone marrow stromal cells 58 antithrombin 58 pancreata 58 C1 INH 58 hepatorenal syndrome 58 progenitor cell 58 ATIR TM 58 romiplostim 58 PLX cells 58 engraftment 58 hES cells 58 transplantation 58 haematopoietic 58 HSCT 58 adipose derived stem cells 58 myoblasts 58 nucleated cells 58 bovine thrombin 58 donor marrow 58 ATIR 57 metastatic malignant 57 thrombocytopenic 57 hepatectomy 57 L asparaginase 57 JAK3 57 colony stimulating factor 57 PROCRIT 57 OrCel R 57 Thrombin 57 CD# + [002] 57 intravesical therapy 57 PROCHYMAL 57 ximelagatran 57 azacitidine 57 SCIg 57 syngeneic 57 allograft 57 renal allograft 57 Xcellerated T Cells 57 intracoronary 57 posaconazole 57 regenerative cells ADRCs 57 vWD 57 decitabine 57 colorectal liver metastases 57 liver transplant recipients 57 colorectal carcinoma 57 ganciclovir 57 platelets plasma 57 hematopoietic stem cells 57 mesenchymal stem cells MSCs 57 FVIIa 57 collagenase 57 immunosuppression 57 Kepivance 57 Intra arterial 57 LVAS 57 oligodendrocyte progenitor cells 57 cell transplantation 57 haematopoietic stem cell 57 transfusion 57 Hizentra 57 busulfan 57 viral inactivation 57 GRNOPC1 cells 57 liver metastases 57 TEMODAL 57 MultiStem 57 corneal graft 56 pathogen inactivation 56 Azacitidine 56 platelets 56 uPA 56 multiple myeloma MM 56 allogeneic transplant 56 bone marrow derived mesenchymal 56 renal transplantation 56 granulocytes 56 edifoligide 56 IMiDs ® compound 56 gastrointestinal stromal tumors GIST 56 autograft 56 acute GvHD 56 allogeneic HSCT 56 G CSF 56 severe neutropenia 56 cerebrospinal fluid CSF 56 neoadjuvant therapy 56 CMV infection 56 prostate carcinoma 56 Factor VIIa 56 rhBMP 2 56 chronic granulomatous disease 56 prostatic tissue 56 ISTODAX 56 cryoprecipitate 56 cutaneous T 56 Gleevec resistant 56 apheresis 56 hematopoietic progenitor cells 56 ECD kidneys 56 donor cornea 56 stromal cell 56 peripheral blood mononuclear 56 oocytes 56 platelet 56 idraparinux 56 Vivaglobin 56 Amrubicin 56 Cyclosporine 56 sorafenib Nexavar 56 Zavesca R 56 mismatched bone marrow 56 VAPRISOL 56 Aprotinin 56 HuMax CD4 56 XYNTHA 56 allograft tissue 56 Interferon alfa 56 candidemia 56 Methylnaltrexone 56 Angiox R 56 invasive aspergillosis 56 deferiprone 56 hESC lines 56 fibrinolytic 56 rilonacept 56 plasma platelets 56 stem progenitor cells 56 B lymphocyte 56 pheochromocytoma 56 cidofovir 56 stromal vascular fraction 56 adipose fat 56 pancreatic islets 56 pediatric acute lymphoblastic 56 cerebral vasospasm 56 TAXUS Stent 56 Revascor TM 56 imipenem 56 bone marrow 56 autologous stem cell 56 allografts 56 chemoembolization 56 allogeneic cell 56 amphotericin B 56 palifermin 55 nephrotoxicity 55 LEUKINE 55 TORISEL 55 Neulasta ® 55 trophoblast cells 55 WinRho R SDF 55 neoplastic cells 55 thrombolytics 55 PBMCs 55 leukemia AML 55 bone marrow stem cells 55 cells MSCs 55 pancreatic tissue 55 HUCB 55 metastatic RCC 55 NGAL 55 OPCAB 55 Adult Stem Cell Therapy 55 fibrin sealants 55 basiliximab 55 #beta estradiol 55 GPIIb IIIa 55 metastatic renal cell carcinoma 55 IV NSCLC 55 pancreatic islet cells 55 pancreatic islet 55 sCD# 55 Granulocyte Colony Stimulating Factor 55 vinorelbine 55 MyVax R 55 ESBA# 55 thrombogenic 55 Torisel 55 hematopoietic blood 55 QuadraSphere 55 rFSH 55 intravenous bolus 55 bone marrow aspirate 55 Tacrolimus 55 ventricular myocardium 55 calcineurin inhibitors 55 keratinocyte 55 transplant HSCT 55 intracoronary infusion 55 VitiGam 55 rituximab Rituxan ® 55 curative therapy 55 external beam radiotherapy 55 fluvastatin 55 IFN ß 55 Neo Bladder Augment 55 hematologic toxicity 55 streptokinase 55 Sym# 55 efalizumab 55 belatacept 55 stem cell engraftment 55 IGIV 55 acellular 55 haematologic 55 somatic cell 55 osteoblastic 55 Decitabine 55 plasma PRP 55 erythropoietic 55 ADRCs 55 parthenogenetic stem cells 55 pulmonary artery banding 55 CryoPatch SG 55 pegfilgrastim 55 PRADAXA 55 plasmin 55 bovine derived 55 NOD SCID mice 55 investigational monoclonal antibody 55 humanized anti 55 mycophenolate mofetil 55 hematologic disorders 55 biotherapies 55 infarcted myocardium 55 recurrent GBM 55 lymphocyte counts 55 hereditary deficiency 55 epithelial tumors 55 contractile muscle 55 candesartan cilexetil 55 Gliadel Wafer 55 saphenous vein grafts 55 cryo preserved 55 platelet transfusion 55 HbF 55 follicular NHL 55 porcine derived 55 endothelial progenitor cells 55 Fludara 55 myoblast 55 GvHD 55 cIAI 55 hemolysis 55 systemic immunosuppressive drugs 55 stem cell transplantations 55 INTERCEPT platelets 55 myofibroblasts 55 tumor recurrence 55 PTHrP 55 tumor lysis syndrome 55 Plasmin 55 PICSO ® 55 RhD positive 54 intramyocardial 54 IL 1ß 54 Hematopoietic 54 HepaGam B 54 osteogenic 54 thoracoscopic lobectomy 54 relapsed multiple myeloma 54 leukoreduction 54 EpCAM 54 metachronous 54 CD4 ^ sup 54 SIR Spheres 54 fibrinogen concentrate 54 invasive candidiasis 54 Alphanate R 54 renal transplants 54 ADPKD 54 GnRH agonists 54 renal transplant 54 vincristine 54 mesenchymal stromal cells 54 IFN beta 54 cytotoxic chemotherapy 54 LHRH agonists 54 tumor lysate 54 radical nephrectomy 54 FXIII 54 IgG 54 VALSTAR 54 von Willebrand 54 myeloablative 54 neoadjuvant chemotherapy 54 urothelial cancer 54 tacrolimus 54 uricase 54 autologous tissue 54 peritoneal carcinomatosis 54 annexin V 54 rFVIII 54 lymphoid organs 54 prostanoid 54 IFN gamma 54 Prolastin C 54 PTLD 54 skeletal myoblasts 54 posttranslational modification 54 AV fistulas 54 WinRho SDF 54 revascularization procedures 54 GTC recombinant human 54 CLL cells 54 ex vivo 54 invasive bladder 54 breast carcinomas 54 Transfusions 54 hemoglobin Hb 54 Dacogen decitabine 54 myeloproliferative diseases 54 Natalizumab 54 thrombin receptor 54 intravenous immunoglobulin 54 Human cl 54 chronic eosinophilic leukemia 54 mTOR inhibitors 54 mitomycin C 54 pro angiogenic 54 CINTREDEKIN BESUDOTOX 54 Alocrest 54 bone marrow transplantation 54 mutated K ras 54 immunosuppressive medications 54 transplanted bone marrow 54 ALDH br cells 54 bioartificial liver 54 epoprostenol 54 kidney transplant recipients 54 xanthine oxidase inhibitor 54 platelet transfusions 54 CD# antibody [001] 54 transplanted islets 54 metaplasia 54 immunosuppressant drug 54 osteoblast 54 VEGF expression 54 mononuclear 54 recombinant factor VIIa 54 hMSCs 54 recurrent glioblastoma multiforme 54 PLX PAD 54 gastrointestinal stromal tumors 54 pegylated liposomal doxorubicin 54 grade cervical intraepithelial 54 epoetin alfa 54 papillary renal cell carcinoma 54 human leukocyte antigens 54 Anaplastic 54 factor VIII 54 Atypical Hemolytic Uremic Syndrome 54 aplastic anemia AA 54 hESC derived 54 refractory angina 54 nonischemic 54 Revascor ™ 54 leukemic cell 54 CHOP chemotherapy 54 nephrectomy 54 liver grafts 54 kidney urologic 54 arteriovenous fistula 54 nitrofurantoin 54 tissue grafts 54 PROCRIT ® 54 fibrotic disease 54 fibrin matrix 54 transarterial 54 reimplantation 54 Mesenchymal 54 recombinant FSH 54 acinar 54 metastatic neuroendocrine tumors 54 cellular immunotherapy 54 bleomycin 54 graft dysfunction 54 Humate P 54 donor nephrectomy 54 GVHD 54 hetastarch 54 retroviral vectors 54 depsipeptide 54 cytoreduction 54 drug zotarolimus 54 peptide antigens 54 trabectedin 54 hyperphenylalaninemia HPA due 54 TYZEKA 54 glomerular filtration 54 proteasome inhibitor 54 transgene expression 54 thrombotic complications 54 Tamibarotene 54 hepatocytes 54 cardiopulmonary bypass CPB 54 recombinant erythropoietin 54 pancreatic adenocarcinoma 54 myelofibrosis polycythemia vera 54 colon carcinoma 54 myeloid 54 NAVISTAR R 54 occlusive disease 54 stage IIIA 54 multipotent cells 54 MYDICAR ® 54 non myeloablative 54 Lenalidomide 54 myelodysplastic syndromes MDS 54 alkylating agent 54 sunitinib Sutent 54 urokinase 54 autologous hematopoietic stem cell 54 Romiplostim 54 xenograft 54 activin 54 penetrating keratoplasty 54 terlipressin 54 mutated KRAS 54 IgG antibodies 54 receptor tyrosine kinase inhibitor 54 radical cystectomy 54 bone marrow transplantations 54 plasminogen activators 54 elacytarabine 54 plasma PRP gel 54 thromboembolism 54 Belatacept 54 antihypertensive agents 54 immunoglobulin Ig 54 islet cells 54 Vaprisol 54 NEUPOGEN 54 Octreolin 54 HepaSphere 54 CentriMag 54 adipogenic 54 umbilical cord stem cells 54 HUCB cells 54 saline placebo 54 hypereosinophilic syndrome 54 ischemic cardiomyopathy 54 BrachySil TM 54 bone morphogenetic protein 53 pouchitis 53 hepatocellular carcinoma 53 effector function 53 Factor VIII 53 rt PA 53 complement inhibitor eculizumab 53 cyclic adenosine monophosphate 53 filgrastim 53 chimeric monoclonal antibody 53 metastatic GIST 53 TNF Tumor Necrosis Factor 53 HoFH 53 pomalidomide 53 reinfusion 53 Mitomycin C 53 hepatitis C HCV 53 Fibrillex TM 53 maribavir 53 monoclonal 53 Doxil ® 53 chronic GVHD 53 neointimal hyperplasia 53 PROMACTA 53 pamidronate 53 Proxinium TM 53 hMG 53 pan HDAC inhibitor 53 prostate adenocarcinoma 53 rhGH 53 tumor specific antigen 53 ER CHOP 53 Ischemic 53 elective PCI 53 lenalidomide Revlimid R 53 5 Fluorouracil 53 VSELs 53 drotrecogin alfa activated 53 myocardium 53 rHuEPO 53 idarubicin 53 plerixafor 53 Dasatinib 53 ARIXTRA 53 erythrocytes 53 lupus nephritis 53 cinacalcet 53 ADAMTS# 53 complete remissions 53 pig islets 53 Chronic myeloid leukemia CML 53 small molecule activators 53 endocrine pancreas 53 hepatocellular carcinomas 53 hemolytic 53 adjuvant radiotherapy 53 androgen receptor AR 53 Pralatrexate 53 erythropoiesis 53 hESCs 53 CANCIDAS 53 Vidofludimus 53 Hepatocellular Carcinoma HCC 53 erythropoietin hormone 53 TACE 53 cystectomy 53 Epoetin alfa 53 chemotherapy induced neutropenia 53 unresectable 53 intravesical instillation 53 cervical carcinoma 53 NEUMUNE 53 carcinoembryonic antigen 53 potassium binder 53 adrenalectomy 53 pancreases 53 resected 53 HeartNet 53 β blockers 53 multipotent 53 symptomatic benign prostatic 53 SynerGraft 53 cellularity 53 lymphoid tissue 53 ovarian carcinoma 53 Aviptadil 53 fluoropyrimidine 53 adhesion molecule 53 Advagraf 53 hpSCs 53 autologous adult 53 sirolimus 53 stage IIIB 53 surrogate endpoint 53 Liver transplantation 53 intradermal injection 53 teratoma 53 recurrent glioma 53 renal tumors 53 Evicel 53 adipose tissue fat 53 Xanafide 53 myeloma cells 53 Fas ligand 53 immunosuppressive regimens 53 von Willebrand disease 53 thromboembolic complications 53 bone morphogenetic proteins 53 PDGF B 53 pluripotent embryonic 53 C#BL 6 mice 53 rituximab 53 HCV infected 53 minimally metabolized 53 transplant ASCT 53 leukemia CLL 53 SSc 53 sarcomatoid 53 AQ4N 53 Neoral 53 therapeutic regimens 53 thrombocytopenic patients 53 cleavable linker 53 CTAP# Capsules 53 TLIF 53 embryonic tissue 53 Surgical resection 53 protein hydrogel 53 LDLT 53 carcinoid 53 diseased tissues 53 ERK1 2 53 VTE prophylaxis 53 dalteparin 53 Vidaza azacitidine 53 hypoxia inducible factor 53 stem cells 53 TG# [003] 53 triacylglycerol 53 embryonic stem cells ESCs 53 EFAPROXYN 53 Certican 53 mononuclear cell 53 idiopathic thrombocytopenic purpura ITP 53 undifferentiated stem cells 53 liposomal doxorubicin 53 neural cells 53 curative resection 53 hematological parameters 53 IL #R 53 mesangial 53 pegylated interferon alfa 53 PAOD 53 surgical aortic valve 53 enucleated 53 cardiopulmonary bypass 53 intracranial hemorrhage ICH 53 daunorubicin 53 hematopoietic stem cells HSCs 53 stem cells harvested 53 β cells 53 IgA antibodies 53 ImmuKnow 53 Leukine ® 53 ZYVOX 53 Bortezomib 53 superficial bladder cancer 53 Accelerated Partial Breast Irradiation 53 octreotide LAR 53 intravenous diuretics 53 HBV infected 53 liposomal formulation 53 catheter angiography 53 FLT3 53 critical limb ischemia 53 Hemospan R 53 preoperative chemotherapy 53 Hemophilia B 53 trans retinoic acid 53 cyclosporine 53 Acute renal failure 53 imetelstat 53 PEGylated anti 53 Haptoglobin 53 arterial thrombosis 53 Velcade bortezomib 53 leukocyte count 53 renal cell carcinomas 53 bevacizumab Avastin ® 53 Renagel ® 53 Rh negative 53 CTLA4 Ig 53 Allograft 53 targeted antifolate 53 chronic immune thrombocytopenic 53 HBsAg 53 mesylate 53 haematological malignancies 53 haematologic malignancies 53 splenectomized patients 53 atypical hemolytic uremic syndrome 53 sodium glucose cotransporter 53 MULTAQ 53 transfemoral 53 Aldosterone 53 tumorigenicity 53 acute humoral rejection 53 SERCA2a 53 Ribavirin causes 53 pancreatic carcinoma 53 Th2 cytokines 53 immunomodulatory therapy 53 MitraClip R 53 Platelets 53 immune globulins 53 OrCel ® 53 amikacin 53 intrahepatic 53 explanted 53 de novo kidney transplant 53 octreotide 53 anti CD3 antibody 53 ABO incompatible 53 endothelial cell 53 protamine 53 transfused blood 53 thyroglobulin 53 hepatocellular carcinoma HCC 53 iron chelation therapy 53 inducible nitric oxide synthase 53 transurethral resection 53 ATryn ® GTC recombinant 53 aT cell 53 PolyHeme 53 HUVEC 53 atypical Hemolytic Uremic Syndrome 53 FRAGMIN R 53 Gammagard Liquid 53 intraoperative 53 umbilical vein 53 thrombus aspiration 53 nutlin 3a 53 NSCLC tumors 53 MabCampath 53 intra arterial 53 epicardium 53 deferoxamine 53 metastatic lung cancer 53 RBC transfusion 53 sclerosing 53 alteplase 53 invasive fungal infections 53 heparanase 53 immunosuppressive medication 53 bronchoalveolar lavage 53 vasopressor 53 OMP #R# 53 Azedra 53 endothelial activation 52 coronary artery bypass grafting 52 activated lymphocytes 52 #beta HSD1 52 retransplantation 52 lung metastases 52 Factor XIII 52 cardiac troponin 52 splenic 52 placental tissue 52 PRT# 52 enzymatically 52 unspecialized cells 52 myeloperoxidase 52 marrow stem cells 52 hpSC 52 TNF alpha antagonist 52 TIMP 52 Circulating tumor cells 52 monocyte derived stem cells 52 biologic DMARD 52 ovarian stimulation 52 dasatinib Sprycel 52 keratoplasty 52 collagens 52 tumor antigen 52 thromboembolic 52 pluripotent cells 52 antimicrobial prophylaxis 52 malignant pleural mesothelioma 52 cell lymphoma CTCL 52 biochemical relapse 52 orchiectomy 52 RLY# 52 immunological reactions 52 Myelodysplastic Syndrome MDS 52 plasma albumin 52 skeletal muscle cells 52 unstable angina UA 52 Olerup SSP 52 aspirin clopidogrel 52 neuropilin 52 myoblast cells 52 Vascular Wrap 52 murine antibodies 52 Interagency Registry 52 Vascugel 52 hypervascular tumors 52 cetuximab Erbitux R 52 Amigal 52 insulin secreting cells 52 gastrointestinal stromal tumors GISTs 52 undergoing hematopoietic stem 52 INFUSE ® 52 acute myelogenous leukemia AML 52 graft occlusion 52 lymphocytosis 52 Endometrial 52 pneumonectomy 52 bone morphogenic protein 52 Cx# [002] 52 direct thrombin inhibitor 52 Noxafil 52 Pentacel vaccine 52 tumoral 52 VFEND 52 immunosuppressive regimen 52 sirolimus stent 52 biologic therapy 52 lentiviral 52 kidney allograft 52 platelet gel 52 immunodeficient mice 52 Umbilical cord blood 52 doxercalciferol 52 progenitor stem cells 52 Calcineurin inhibitors 52 CGRP 52 cardiogenic 52 steroidogenesis 52 vertebral compression fractures 52 NAGS deficiency 52 autogenous bone graft 52 hemodialysis patients 52 Vascular Grafts 52 carotid artery stenting 52 apoptotic pathway 52 mouse testes 52 relapsing multiple sclerosis 52 unfertilized human 52 immunosuppressants 52 CMV reactivation 52 Eculizumab 52 Anti Bacterial Envelope 52 Everolimus 52 humanized antibody 52 carotid plaque 52 inotropes 52 rituximab Rituxan 52 euthyroid 52 concurrent chemoradiation 52 variceal hemorrhage 52 Subarachnoid hemorrhage 52 umbilical cord blood 52 PEGylated Fab fragment 52 coronary stent merged 52 alefacept 52 acute GVHD 52 inotropic 52 chlorambucil 52 Tavocept 52 multipotent stem cells 52 Mimpara 52 thoracic aortic aneurysms 52 nephron 52 neuronal stem cells 52 human leukocyte antigen 52 polyclonal antibody 52 antifungal therapy 52 peptide BNP 52 YONDELIS 52 Bone marrow transplantation 52 bone marrow stem cell 52 malignant ascites 52 ischemia reperfusion injury 52 partial nephrectomy 52 thrombolytic agents 52 HLA antigens 52 chemoresistant 52 interferon IFN 52 neutropenic patients 52 EXJADE 52 sitaxsentan 52 thymidylate synthase TS 52 elotuzumab 52 aldosterone antagonist 52 chemoradiotherapy 52 titrated glipizide 52 C1INH 52 glycosylated 52 IL 1beta 52 Neupogen ® 52 neoplastic 52 purpura ITP 52 revascularization 52 Paraplatin ® 52 adverse cytogenetics 52 perioperative complications 52 A1PI 52 FOLOTYN ® 52 regenerative medicine therapies 52 mitomycin 52 Alemtuzumab 52 Taliglucerase alfa 52 INTERCEPT treated 52 juvenile chondrocytes 52 Telintra 52 pancreatectomy 52 aortic dissections 52 hepatic metastases 52 eplerenone 52 Toxicities 52 elevated triglyceride levels 52 Helixate FS 52 FOLFOX4 52 Adjuvant chemotherapy 52 neuroendocrine cancers 52 TAXUS TM 52 noninfectious uveitis 52 thromboprophylaxis 52 PEGylated 52 antithymocyte globulin 52 gastric adenocarcinoma 52 osteochondral 52 paricalcitol 52 docetaxel Taxotere ® 52 fibrin sealant 52 serotonin synthesis 52 chronic hemodialysis 52 viremic 52 Critical Limb Ischemia CLI 52 voriconazole 52 severe hypersensitivity reactions 52 relapsed SCLC 52 lung transplantation 52 pentostatin 52 Prochymal 52 acute ischemic stroke 52 percutaneously 52 plasmid DNA vaccine 52 TIMP 1 52 colony stimulating factors 52 pancreatic endocrine 52 Platelet 52 saphenous vein graft 52 AFRS TM 52 Certolizumab pegol 52 amrubicin 52 engrafted cells 52 functional mitral regurgitation 52 valve implantation 52 thyrotropin 52 postoperative morbidity 52 non splenectomized 52 corticosteroid therapy 52 cell lymphomas 52 OPAXIO 52 HER2 overexpression 52 Proleukin 52 poloxamer 52 P#X# 52 rFVIIIFc 52 aprotinin 52 dasatinib Sprycel ® 52 milatuzumab 52 Pathway Inhibitor 52 Cardiopulmonary bypass 52 mesenchymal cells 52 ADP receptor antagonist 52 ISF# 52 Cutaneous T 52 reperfusion 52 thalidomide Thalomid 52 surgical revascularization 52 Cell TRC 52 glycoprotein IIb IIIa inhibitors 52 Nilotinib 52 homozygous familial hypercholesterolemia 52 prostate cancer CRPC 52 hypercalcemia 52 Epratuzumab 52 Soliris eculizumab 52 thromboembolic disease 52 Gleevec imatinib mesylate